Business Breaking Down Novavax’s Coronavirus Vaccine Data: 2 Analyst Takes News Desk January 30, 2021 Novavax, Inc. (NASDAQ: NVAX) shares were roaring higher Friday after the company reported topline results from the late-stage trial of its coronavirus vaccine candidate in the U.K. The Novavax Analyst: …